炎症性肠病
溃疡性结肠炎
医学
疾病
药品
克罗恩病
体内
临床试验
免疫学
药物开发
治疗方法
治疗效果
药理学
内科学
生物
生物技术
作者
Yaxi Zhou,Diandian Wang,Wenjie Yan
出处
期刊:Nutrients
[MDPI AG]
日期:2023-02-18
卷期号:15 (4): 1031-1031
被引量:21
摘要
Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory disease of the intestine that can be classified as ulcerative colitis (UC) and Crohn's disease (CD). Currently, the incidence of IBD is still increasing in developing countries. However, current treatments for IBD have limitations and do not fully meet the needs of patients. There is a growing demand for new, safe, and highly effective alternative drugs for IBD patients. Natural products (NPs) are used in drug development and disease treatment because of their broad biological activity, low toxicity, and low side effects. Numerous studies have shown that some NPs have strong therapeutic effects on IBD. In this paper, we first reviewed the pathogenesis of IBD as well as current therapeutic approaches and drugs. Further, we summarized the therapeutic effects of 170 different sources of NPs on IBD and generalized their modes of action and therapeutic effects. Finally, we analyzed the potential mechanisms of NPs for the treatment of IBD. The aim of our review is to provide a systematic and credible summary, thus supporting the research on NPs for the treatment of IBD and providing a theoretical basis for the development and application of NPs in drugs and functional foods.
科研通智能强力驱动
Strongly Powered by AbleSci AI